Abbott Laboratories vs GE HealthCare
Abbott Laboratories reported revenue of $44.3 billion in fiscal 2025, 2.1 times GE HealthCare's $20.6 billion in fiscal 2025. Abbott Laboratories' revenue grew 5.7% in its latest year, and GE HealthCare's grew 4.8%. Abbott Laboratories had an operating margin of 18.2%, against 13.4% at GE HealthCare. Free cash flow was $7.4 billion at Abbott Laboratories and $1.5 billion at GE HealthCare.
Side by side
| Abbott Laboratories | GE HealthCare | |
|---|---|---|
| Latest fiscal year | FY2025, Dec 31, 2025 | FY2025, Dec 31, 2025 |
| Revenue | $44.3B | $20.6B |
| Revenue growth | 5.7% | 4.8% |
| Revenue growth a year, last 5 years | 5.1% | — |
| Gross margin | 56.4% | 40.0% |
| Operating margin | 18.2% | 13.4% |
| Net margin | 14.7% | 10.1% |
| Free cash flow | $7.4B | $1.5B |
| Free cash flow margin | 16.7% | 7.3% |
| Return on capital | 11.2% | 13.2% |
| Net debt to EBITDA | 0.4x | 1.8x |
| Dividends and buybacks | $5.0B | $264M |
| Change in diluted share count | 0.0% | −0.2% |
| Last close | $104.88 | $71.98 |
| P/E at the last close | 29.3× | 17.2× |
| Insider trades, last 12 months | bought $4.4 million, sold $47.5 million | bought $6.4 million, sold $0 |
| Piotroski F-score | 6 of 9 | 7 of 9 |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
Abbott LaboratoriesGE HealthCare
Operating margin
Percent of revenue
Abbott LaboratoriesGE HealthCare
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Abbott LaboratoriesGE HealthCare
Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Abbott Laboratories and GE HealthCare pages.